CISPLATIN Side Effects

7027160-0 | Neutrophil Count Decreased
on Sep 30, 2010 Male patient from UNITED STATES , weighting 156.3 lb, was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. Cisplatin dosage: 142.5 Mg. During the same period patient was treated with VINORELBINE TARTRATE (114 Mg) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ).

7023664-5 | Neutrophil Count Decreased
Patient was taking Cisplatin (View Usage). Patient had the following side effects: neutrophil count decreased on Sep 29, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 147.7 lb, . Cisplatin dosage: 135 Mg. During the same period patient was treated with ETOPOSIDE (510 Mg) (View Etoposide Review and Etoposide Label ).

7023653-0 | Neutrophil Count Decreased
Adverse event was reported on Sep 29, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 162 Mg) . Location: UNITED STATES , weighting 198.6 lb, After Cisplatin was administered, patient had the following side effects: neutrophil count decreased. During the same period patient was treated with ETOPOSIDE (609 Mg) (View Etoposide Review and Etoposide Label ).

7023513-5 | Nausea
on Sep 29, 2010 Male patient from UNITED STATES , 54 years of age, weighting 154.3 lb, was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Cisplatin dosage: 124 Mg Once Iv. During the same period patient was treated with ETOPOSIDE (124 Mg Every Day Iv) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.


7022990-3 | Renal Failure Acute
on Sep 29, 2010 Female patient from JAPAN , 46 years of age, weighting 125.7 lb, was diagnosed with cervix carcinoma recurrent, tumour pain, constipation (What is constipation?), abdominal pain upper and was treated with Cisplatin (View Usage). Patient had the following side effects: renal failure acute. Cisplatin dosage: Cycle 1 (78mg):12apr10 Cycle 7 (73.5):25aug10. During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ), DICLOFENAC SODIUM (Suppository; 50mg Tid) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

7022097-5 | Duodenal Ulcer Haemorrhage, Oesophageal Ulcer
Patient was taking Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: duodenal ulcer haemorrhage, oesophageal ulcer on Sep 28, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 251.3 lb, was diagnosed with non-small cell lung cancer and. Cisplatin dosage: 2nd + Recent Inf On:07jul2010. During the same period patient was treated with ALIMTA (2nd + Recent Inf On:07jul2010) (View Alimta Review and Alimta Label ), NECITUMUMAB (View Necitumumab Review and Necitumumab Label ), IBUPROFEN (Every 4 To 6 Hours) (View Ibuprofen Review and Ibuprofen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

7019606-9 | Blood Albumin Decreased, Blood Chloride Decreased, Blood Sodium Decreased, Febrile Neutropenia, Haemoglobin Decreased, Urinary Tract Infection, White Blood Cell Count Decreased
Adverse event was reported on Sep 28, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 100 Mg) . Location: UNITED STATES , weighting 271.6 lb, Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, febrile neutropenia, haemoglobin decreased, urinary tract infection (What is urinary tract infection?), white blood cell count decreased. During the same period patient was treated with ALIMTA (1000 Mg) (View Alimta Review and Alimta Label ). Patient was hospitalized.

7019588-X | Bacteraemia, Dehydration, Escherichia Test Positive, Urinary Tract Infection
on Sep 28, 2010 Female patient from UNITED STATES , weighting 154.3 lb, was treated with Cisplatin (View Usage). Patient had the following side effects: bacteraemia, dehydration, escherichia test positive, urinary tract infection (What is urinary tract infection?). Cisplatin dosage: 130 Mg. During the same period patient was treated with ETOPOSIDE (525 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

7018738-9 | Neutropenia, Sepsis, Thrombocytopenia
on Sep 27, 2010 Male patient from UNITED STATES , 66 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: neutropenia, sepsis (What is sepsis?), thrombocytopenia. Cisplatin dosage: Discontinued On 03aug10. During the same period patient was treated with NECITUMUMAB (Liquid) (View Necitumumab Review and Necitumumab Label ), ALIMTA (Discontinued On 03aug10) (View Alimta Review and Alimta Label ), SERETIDE (Diskus) (View Seretide Review and Seretide Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), DALACIN (View Dalacin Review and Dalacin Label ), ELOCON (View Elocon Review and Elocon Label ), QUAMATEL (View Quamatel Review and Quamatel Label ).

7018188-5 | Sarcoidosis
Patient was taking Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: sarcoidosis on Sep 20, 2010 from JAPAN Additional patient health information: Male patient , 36 years of age, was diagnosed with seminoma and. Cisplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), BLEOMYCIN (View Bleomycin Review and Bleomycin Label ).

7018170-8 | Gastrointestinal Perforation
Adverse event was reported on Sep 17, 2010 by a Male patient taking Cisplatin (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: JAPAN , weighting 130.5 lb, Patient had the following side effects: gastrointestinal perforation. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), ANTIXIB (View Antixib Review and Antixib Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

7018131-9 | Atelectasis, Atrial Fibrillation, Chest Pain, Dehydration, Dialysis, Enterocolitis Infectious, Hyperglycaemia, Hypotension, Pancytopenia
on Sep 27, 2010 Male patient from UNITED STATES , 68 years of age, weighting 170.0 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: atelectasis, atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?), dehydration, dialysis (What is dialysis?), enterocolitis infectious, hyperglycaemia, hypotension, pancytopenia. Cisplatin dosage: 80mg/m2 Q28d Iv. During the same period patient was treated with FLUOROURACIL (1000mg/m2/day Q28 Over 96 Hr Iv) (View Fluorouracil Review and Fluorouracil Label ), PANITUMUMAB (View Panitumumab Review and Panitumumab Label ). Patient was hospitalized.

7017828-4 | Deep Vein Thrombosis
on Sep 27, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Cisplatin dosage: 513 Mg. Patient was hospitalized.

7017387-6 | Intestinal Perforation, Malignant Neoplasm Progression, Peritonitis
Patient was taking Cisplatin (View Usage). Patient had the following side effects: intestinal perforation, malignant neoplasm progression, peritonitis on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer, nausea (What is nausea?), pain (What is pain?), chronic obstructive pulmonary disease and. Cisplatin dosage: Initial Dose 116mg From 1jul10-unk Date Again From 22jul10-22jul10 (94mg);2nd+recent Inf. During the same period patient was treated with NECITUMUMAB (Liquid 2nd+recent Inf:22jul2010(800mg). From01jul10-unk Date Again From 22jul10-22jul10) (View Necitumumab Review and Necitumumab Label ), ALIMTA (Initial Dose:1jul2010(775mg) From 1jul10-unk Date Again From 22jul10-22jul10(425mg);2nd+recent Inf) (View Alimta Review and Alimta Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATROVENT (View Atrovent Review and Atrovent Label ), BRICANYL (With Sodium Chloride) (View Bricanyl Review and Bricanyl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

7015592-6 | Dehydration, Mucosal Inflammation, Neutropenia
Adverse event was reported on Sep 24, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: ) was diagnosed with gastrooesophageal cancer and. Location: GERMANY , 81 years of age, weighting 130.1 lb, After Cisplatin was administered, patient had the following side effects: dehydration, mucosal inflammation, neutropenia. During the same period patient was treated with CAPECITABINE (Tablet,day 1-15; Interrupted On 05apr2010. Most Recent Inf On 05apr10.13apr10 Withdrawn From Study) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

7014809-1 | Sarcoidosis
on Sep 22, 2010 Male patient from JAPAN , 32 years of age, was diagnosed with seminoma and was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: sarcoidosis. Cisplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ).

7014806-6 | Convulsion, Multi-organ Failure, Pneumatosis Intestinalis, Portal Venous Gas, Shock
on Sep 24, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with oesophageal carcinoma and was treated with Cisplatin (View Usage). Patient had the following side effects: convulsion, multi-organ failure, pneumatosis intestinalis, portal venous gas, shock. Cisplatin dosage: On Days 1-15 For 24 Hours. During the same period patient was treated with FLUOROURACIL (On Days 1-5 For 24 Hours) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

7014686-9 | Portal Venous Gas
Patient was taking Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: portal venous gas on Sep 21, 2010 from JAPAN Additional patient health information: Male patient , 40 years of age, was diagnosed with oesophageal carcinoma and. Cisplatin dosage: 10 Mg/body. During the same period patient was treated with FLUOROURACIL (500 Mg/body) (View Fluorouracil Review and Fluorouracil Label ).

7013992-1 | Coagulation Time Prolonged, Diarrhoea
Adverse event was reported on Sep 23, 2010 by a Male patient taking Cisplatin (View Usage) (Dosage: Day 1 Of Cycle First Inf:29mar10 Recent:11may10 No. Of Inf:3 Interrupted:01jun10) was diagnosed with gastrooesophageal cancer and. Location: GERMANY , 67 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: coagulation time prolonged, diarrhoea. During the same period patient was treated with XELODA (First Dose:29mar10 Recent Dose:19may10 No Of Inf:3,) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7013591-1 | Abdominal Pain Upper, Chest Pain, Coagulopathy, Convulsion, Delirium, Dyspnoea, Endotracheal Intubation, Haematemesis, Mechanical Ventilation
on Sep 15, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with oesophageal carcinoma and was treated with Cisplatin (View Usage). Patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), coagulopathy, convulsion, delirium, dyspnoea, endotracheal intubation, haematemesis, mechanical ventilation. Cisplatin dosage: 10 Mg/body On Days 1- 5 For 24 Hours. During the same period patient was treated with FLUOROURACIL (500 Mg/body On Days 1-5 For 24 Hours) (View Fluorouracil Review and Fluorouracil Label ).

7012126-7 | Hydronephrosis, Ureteric Dilatation, Ureteric Obstruction, Urinary Tract Infection
on Sep 22, 2010 Female patient from UNITED STATES , weighting 146.3 lb, was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: hydronephrosis, ureteric dilatation, ureteric obstruction, urinary tract infection (What is urinary tract infection?). Cisplatin dosage: 50 Mg. During the same period patient was treated with TAXOL (175 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7012118-8 | Chest Pain, Dyspnoea, Herpes Zoster, White Blood Cell Count Decreased
Patient was taking Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, herpes zoster, white blood cell count decreased on Sep 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 252.0 lb, . Cisplatin dosage: 100 Mg. During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7011451-3 | Febrile Neutropenia, Thrombocytopenia
Adverse event was reported on Sep 22, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 20mg/m2) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 143.0 lb, Patient had the following side effects: febrile neutropenia, thrombocytopenia. During the same period patient was treated with TAXOL (20mg/m2 Weekly) (View Taxol Review and Taxol Label ), RAD001 (5mg Daily) (View Rad001 Review and Rad001 Label ). Patient was hospitalized.

7010832-1 | Febrile Neutropenia, Metastatic Neoplasm
on Sep 23, 2010 Female patient from UNITED STATES , weighting 178.4 lb, was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: febrile neutropenia, metastatic neoplasm. Cisplatin dosage: 117 Mg. During the same period patient was treated with ETOPOSIDE (411 Mg) (View Etoposide Review and Etoposide Label ), TOPOTECAN (4.5 Mg) (View Topotecan Review and Topotecan Label ). Patient was hospitalized.

7009268-9 | Hydronephrosis
on Sep 21, 2010 Female patient from JAPAN , 46 years of age, weighting 125.7 lb, was diagnosed with cervix carcinoma and was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: hydronephrosis. Cisplatin dosage: 73.5mg;cycle 7;restarted:25aug2010.. During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ). Patient was hospitalized.

7007148-6 | Dyspnoea, Prothrombin Time Prolonged, Pulmonary Embolism
Patient was taking Cisplatin (View Usage). Patient had the following side effects: dyspnoea, prothrombin time prolonged, pulmonary embolism (What is pulmonary embolism?) on Sep 09, 2010 from GERMANY Additional patient health information: Male patient , 55 years of age, weighting 110.2 lb, was diagnosed with gastrooesophageal cancer and. Cisplatin dosage: On Day 1 Of Cycle Recent Inf:09sep09. During the same period patient was treated with XELODA (On Day 1-15 Tabs Recent Inf:17sep09) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7006688-3 | Vomiting
Adverse event was reported on Sep 20, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: On Day 1 Of Cyc) was diagnosed with gastrooesophageal cancer and. Location: GERMANY , 59 years of age, weighting 127.9 lb, After Cisplatin was administered, patient had the following side effects: vomiting. During the same period patient was treated with XELODA (Tabs On Day 1-15) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7006607-X | Cellulitis, Deep Vein Thrombosis, Neuropathy Peripheral
on Sep 21, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), neuropathy peripheral. Cisplatin dosage: 513 Mg. Patient was hospitalized.

7005791-1 | Deep Vein Thrombosis, Pulmonary Embolism
on Sep 20, 2010 Male patient from GERMANY , 59 years of age, weighting 224.9 lb, was diagnosed with gastrooesophageal cancer and was treated with Cisplatin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Cisplatin dosage: Day 1 Of Cycle. Recent Infusion: 16apr09 Temporarily Discontinued On 06may2009. During the same period patient was treated with XELODA (Form=tab,on Day 1-15;recent Dose-30apr09,1st Intake(current Cyc):16apr09,temp Discont-06may2009) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

7005385-8 | Atelectasis, Atrial Fibrillation, Blood Creatinine Increased, Chest Pain, Diarrhoea, Enterocolitis, Hypotension, Nausea, Sepsis
Patient was taking Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: atelectasis, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, chest pain (What is chest pain?), diarrhoea, enterocolitis, hypotension, nausea (What is nausea?), sepsis (What is sepsis?) on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 170.0 lb, was diagnosed with oesophageal adenocarcinoma and. Cisplatin dosage: 80mg/2 Q28d Iv. During the same period patient was treated with FLUOROURACIL (1000mg/m2/day Q28d, Over 96 Hour Iv) (View Fluorouracil Review and Fluorouracil Label ), PANITUMUMAB (View Panitumumab Review and Panitumumab Label ). Patient was hospitalized and became disabled.

7005058-1 | Dehydration, Escherichia Urinary Tract Infection, Nausea
Adverse event was reported on Sep 20, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 130 Mg) . Location: UNITED STATES , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: dehydration, escherichia urinary tract infection, nausea (What is nausea?). During the same period patient was treated with ETOPOSIDE (525 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

7005002-7 | Pulmonary Embolism
on Sep 20, 2010 Male patient from GERMANY , 63 years of age, weighting 108.0 lb, was diagnosed with gastrooesophageal cancer and was treated with Cisplatin (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Cisplatin dosage: On Day 1 Of Cycle Recent Inf : 20jul09 Interrupted On 11aug09. During the same period patient was treated with XELODA (On Day 1-15 Recent Inf : 04aug09 Interrupted On 11aug09) (View Xeloda Review and Xeloda Label ). Patient was hospitalized and became disabled.

7002946-7 | Portal Venous Gas
on Sep 09, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with oesophageal carcinoma and was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: portal venous gas. Cisplatin dosage: 10 Mg/body. During the same period patient was treated with FLUOROURACIL (500 Mg/body) (View Fluorouracil Review and Fluorouracil Label ).

6999813-1 | Pneumonia Aspiration
Patient was taking Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia aspiration on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, . Cisplatin dosage: .

6999811-8 | Mallory-weiss Syndrome, Vomiting
Adverse event was reported on Sep 15, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 75mg/m2 On Day 1 Every 21 Days.) was diagnosed with non-small cell lung cancer metastatic, nausea (What is nausea?) and. Location: UNITED STATES , 47 years of age, weighting 105.8 lb, Patient had the following side effects: mallory-weiss syndrome, vomiting. During the same period patient was treated with PEMETREXED DISODIUM (Vial:500mg/m2 On Day 1 Every 21 Days.) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6993033-2 | Febrile Neutropenia
on Sep 16, 2010 Female patient from UNITED STATES , weighting 143.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: febrile neutropenia. Cisplatin dosage: 20mg/m2. During the same period patient was treated with TAXOL (70mg/m2 Weekly) (View Taxol Review and Taxol Label ), RAD001 (5 Mg Daily) (View Rad001 Review and Rad001 Label ). Patient was hospitalized.

6987839-3 | Aortic Thrombosis, Blood Fibrinogen Increased, Platelet Count Increased
on Sep 03, 2010 Male patient from KOREA, REPUBLIC OF , 50 years of age, was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: aortic thrombosis, blood fibrinogen increased, platelet count increased. Cisplatin dosage: 60mg/m2 On Day 1/ Every Three Weeks/ Iv. During the same period patient was treated with ETOPOSIDE (100mg/m2 On Days 1-3/ Every Three Weeks/ I) (View Etoposide Review and Etoposide Label ).

6987816-2 | Acute Myocardial Infarction, Coronary Artery Occlusion, Coronary Artery Thrombosis, Electrocardiogram St Segment Depression, Electrocardiogram St Segment Elevation, Gene Mutation Identification Test Positive
Patient was taking Cisplatin (View Usage). Patient had the following side effects: acute myocardial infarction, coronary artery occlusion, coronary artery thrombosis, electrocardiogram st segment depression, electrocardiogram st segment elevation, gene mutation identification test positive on Sep 03, 2010 from TURKEY Additional patient health information: Male patient , 43 years of age, was diagnosed with metastases to lung and. Cisplatin dosage: 20mg/m2 (37mg) For 5 Days. During the same period patient was treated with ETOPOSIDE (100 Mg/m2 (187mg) For 5 Days) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6987468-1 | Nausea, Vertigo
Adverse event was reported on Sep 14, 2010 by a Male patient taking Cisplatin (View Usage) (Dosage: Recent Dose 28-jul-2010.) was diagnosed with non-small cell lung cancer, prophylaxis, insomnia, hypokalaemia and. Location: UNITED STATES , 54 years of age, weighting 158.7 lb, After Cisplatin was administered, patient had the following side effects: nausea (What is nausea?), vertigo. During the same period patient was treated with PEMETREXED DISODIUM (Recent Dose 28-jul-2010.interrupted On 18aug2010; Restarted On 20aug2010) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (Recent Dose 28-jul-2010. Interrupted On 18aug2010; Restarted On 20aug2010) (View Bevacizumab Review and Bevacizumab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), KALINOR (View Kalinor Review and Kalinor Label ), CALCILAC (Calcilac Kt) (View Calcilac Review and Calcilac Label ). Patient was hospitalized.

6987467-X | Intestinal Perforation, Malignant Neoplasm Progression, Peritonitis
on Sep 07, 2010 Male patient from UNITED STATES , 73 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer, nausea (What is nausea?), pain (What is pain?), chronic obstructive pulmonary disease and was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation, malignant neoplasm progression, peritonitis. Cisplatin dosage: Initial Dose 116mg From 1jul10-unk Date Again From 22jul10-22jul10 (94mg);2nd+recent Inf. During the same period patient was treated with NECITUMUMAB (Liquid 2nd+recent Inf:22jul2010(800mg). From01jul10-unk Date Again From 22jul10-22jul10) (View Necitumumab Review and Necitumumab Label ), ALIMTA (Initial Dose:1jul2010(775mg) From 1jul10-unk Date Again From 22jul10-22jul10(425mg);2nd+recent Inf) (View Alimta Review and Alimta Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATROVENT (View Atrovent Review and Atrovent Label ), BRICANYL (With Sodium Chloride) (View Bricanyl Review and Bricanyl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6984863-1 | Nausea, Oesophageal Pain
on Sep 10, 2010 Male patient from UNITED STATES , 61 years of age, weighting 176.4 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Cisplatin (View Usage). Patient had the following side effects: nausea (What is nausea?), oesophageal pain. Cisplatin dosage: Day 1,8,15,22,29,36;total Dose=287.95mg;dose(5th Course)=47.75mg;dose(6th Course)=38.2mg. During the same period patient was treated with TAXOL (Day 1,8,15,22,29,36;total Dose=575.9mg;dose(5th Course)=95.5mg;dose(6th Course)=76.4mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6984699-1 | Blood Glucose Increased, Pulmonary Embolism
Patient was taking Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: blood glucose increased, pulmonary embolism (What is pulmonary embolism?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 240.5 lb, . Cisplatin dosage: 200 Mg. Patient was hospitalized.

6983418-2 | Anaemia, Colitis Ischaemic, Febrile Neutropenia, Gardnerella Test Positive, Hypokalaemia, Hyponatraemia, Rectal Haemorrhage, Sinus Tachycardia
Adverse event was reported on Sep 14, 2010 by a Female patient taking Cisplatin (View Usage) (Dosage: 479 Mg) . Location: UNITED STATES , weighting 109.1 lb, Patient experienced the following unwanted or unexpected effects: anaemia, colitis ischaemic, febrile neutropenia, gardnerella test positive, hypokalaemia, hyponatraemia, rectal haemorrhage, sinus tachycardia. During the same period patient was treated with ETOPOSIDE (1803 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6983414-5 | Ascites, Hypoxia, Nephrectomy, Pericardial Effusion, Peritoneal Dialysis, Pleural Effusion, Pulmonary Haemorrhage, Renal Failure
on Sep 14, 2010 Female patient from UNITED STATES , weighting 23.81 lb, was treated with Cisplatin (View Usage). Patient had the following side effects: ascites, hypoxia, nephrectomy, pericardial effusion, peritoneal dialysis, pleural effusion, pulmonary haemorrhage, renal failure. Cisplatin dosage: 72 Mg. During the same period patient was treated with ETOPOSIDE (216 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6982074-7 | Blood Pressure Decreased, Coronary Artery Occlusion, Myocardial Infarction
on Aug 24, 2010 Male patient from TURKEY , 43 years of age, was diagnosed with testis cancer and was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: blood pressure decreased, coronary artery occlusion, myocardial infarction. Cisplatin dosage: (20 Mg/m2, Fior 5 Days). During the same period patient was treated with BLEOMYCIN SULFATE ((100 Mg/m2, For 5 Days)) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), ETOPOSIDE ((30 Mg, For 2 Days)) (View Etoposide Review and Etoposide Label ).

6979612-7 | Back Pain, Bacterial Test, Chills, Neutrophil Count Decreased, Pyrexia, White Blood Cell Count Decreased, White Blood Cells Urine Positive
Patient was taking Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), bacterial test, chills, neutrophil count decreased, pyrexia, white blood cell count decreased, white blood cells urine positive on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 170.4 lb, . Cisplatin dosage: 141 Mg. During the same period patient was treated with ETOPOSIDE (564 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6979461-X | Haematotoxicity, Hypersensitivity
Adverse event was reported on Aug 24, 2010 by a Male patient taking Cisplatin (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: CZECH REPUBLIC , 51 years of age, Patient had the following side effects: haematotoxicity, hypersensitivity. During the same period patient was treated with GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), ERLOTINIB HYDROCHLORIDE (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ).

6979449-9 | Aortic Thrombosis, Hypercoagulation
on Aug 24, 2010 Male patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 50 years of age, was treated with Cisplatin (View Usage). After Cisplatin was administered, patient had the following side effects: aortic thrombosis, hypercoagulation. Cisplatin dosage: (60 Mg/m2, Day 1). During the same period patient was treated with ETOPOSIDE ((days 1-3 Every 3 Weeks) Intravenous) (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6979447-5 | Haematotoxicity, Malignant Neoplasm Progression, Non-small Cell Lung Cancer
on Aug 24, 2010 Female patient from CZECH REPUBLIC , 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Cisplatin (View Usage). Patient experienced the following unwanted or unexpected effects: haematotoxicity, malignant neoplasm progression, non-small cell lung cancer. Cisplatin dosage: . During the same period patient was treated with GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6975586-3 | Colitis, Febrile Neutropenia, Peripheral Ischaemia
Patient was taking Cisplatin (View Usage). Patient had the following side effects: colitis, febrile neutropenia, peripheral ischaemia on Sep 07, 2010 from GERMANY Additional patient health information: Female patient , 50 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer, hypertension, dysaesthesia, myalgia, pain in extremity, ischaemia and. Cisplatin dosage: Recent Admn:23jul2010,06aug10 Strength 1mg/1ml. During the same period patient was treated with TAXOL (Recent Admn:23jul2010 Strength:6mg/ml) (View Taxol Review and Taxol Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), DIOVAN HCT (Co Diovan 160/25 1df=1 Tab) (View Diovan Hct Review and Diovan Hct Label ), LYRICA (Lyrica 75 2df=2 Tab) (View Lyrica Review and Lyrica Label ), IBUPROFEN (Ibuprofen 40 2df=2 Tabs) (View Ibuprofen Review and Ibuprofen Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ). Patient was hospitalized.